Bronchinal
Bronchinal, licence 80069413: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- ÉQUILIBRE SANTÉ NATUREL INC.
- NPN or DIN-HM
- 80069413
- Status
- Active licence
- Licence date
- 13 May 2016
- Revision date
- 30 October 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ulmus rubra Source : Ulmus rubra - Écorce interne (tige) | 50.0 milligramme | Not calculated |
| Thymus vulgaris Source : Feuille | 250.0 milligramme | Not calculated |
| Eucalyptus globulus Source : Feuille | 100.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | minimum: 2.0 Jour(s) ; maximum: 3.0 Jour(s) |
Uses authorised in Canada
Utilisé traditionnellement en phytothérapie comme expectorant pour aider à soulager les symptômes de la bronchite et du rhume, et pour aider à soulager la toux (spasmolytique).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si de la difficulté respiratoire, de la fièvre ou des expectorations purulentes surviennent, ou si les symptômes persistent ou s'aggravent au-delà de 7 jours consécutifs. Consulter un praticien de soins de santé avant utilisation si vous souffrez d'inflammation du système gastro-intestinal ou des canaux biliaires ou si vous avez une maladie du foie.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou si vous allaitez.
- Précautions et mises en garde
Une hypersensibilité peut se manifester. Si tel est le cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80069413
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.